HealthDay
(5/4, Gordon) reports that the American College of Rheumatology has
crafted new guidelines for the screening and management of a
"potentially devastating complication of lupus" involving the presence
of kidney inflammation in patients. This condition, also known as lupus
nephritis, "can lead to end-stage-renal disease, which requires
dialysis or a kidney transplant," according to lead author Dr. Bevra
Hahn, chief of rheumatology at the David Geffen School of Medicine at
the University of California, Los Angeles. Hahn adds
that "not all types are this serious. It depends on the pattern of
damage to the kidneys." HealthDay notes that the guidelines recommend a
kidney biopsy if a patient has not received treatment for lupus
nephritis and has shown signs of kidney involvement. The information
from the biopsy helps doctors decide what treatments to prescribe.
WebMD
(5/4, Mann) mentions that "about 1.5 million Americans have lupus, and
one-third of them will develop kidney involvement, or lupus nephritis,
as a result, according to the Lupus Foundation of America." The new ACR
guidelines on lupus nephritis appear in the journal Arthritis Care
& Research.
No comments:
Post a Comment